Optometrists in El Dorado, KS Accepting Medicare
11 Optometrists found. Showing 1 - 11
 Robert A Moore, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1400 W Central Ave, El Dorado, KS 67042 Phone: 316-320-2200 Fax: 316-321-0430 |
 Grene Vision Group Optometrist Medicare: Medicare Enrolled Practice Location: 1400 W Central, El Dorado, KS 67042 Phone: 316-320-2200 Fax: 316-320-0430 |
 Dr. Kathryn Jane Hamm, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1400 W Central Ave, El Dorado, KS 67042 Phone: 316-320-2200 Fax: 316-320-0430 |
Christopher A Smith Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 2422 W Central Ave, Suite C, El Dorado, KS 67042 Phone: 316-452-5999 |
Drs Joyce & Hursh, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 201 N Vine St, El Dorado, KS 67042 Phone: 316-321-4020 Fax: 316-321-0115 |
Heather H. Wooten, O.d., P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2348 W Central Ave, Suite B, El Dorado, KS 67042 Phone: 316-321-7732 |
Dr. Gregory Paul Joyce, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 201 N Vine St, El Dorado, KS 67042 Phone: 316-321-4020 Fax: 316-321-0115 |
Grene Vision Group Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1400 W Central, El Dorado, KS 67042 Phone: 316-320-2200 Fax: 316-321-0430 |
Dr. Christopher Allen Smith, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2422 W Central Ave, Suite C, El Dorado, KS 67042 Phone: 316-452-5999 Fax: 316-452-5624 |
Marcus S Randall, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1400 W Central Ave, El Dorado, KS 67042 Phone: 316-320-2200 Fax: 316-320-0430 |
Mrs. Amanda Lee Hursh, O.D, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 201 N Vine St, El Dorado, KS 67042 Phone: 316-321-4020 Fax: 316-321-0115 |
News Archive
Data illustrates methods for improving adherence to medication, lowering prescription drug costs
CVS Caremark presented data at the 22nd Annual Meeting of the Academy of Managed Care Pharmacy that illustrate successful methods for improving adherence to medication and lowering prescription drug costs. The company showed results from three studies which demonstrated the positive impact of various tools available to pharmacy benefit managers – including automated telephonic messaging, fax alerts to physicians about gaps in care, and strategic co-pay waivers for generic medications.
Childhood obesity: an interview with Dr. Kevin Hall, NIDDK, National Institutes of Health, Bethesda, USA
Our research uses mathematical modelling to quantify calorie intake as children grow at a healthy rate as well as when they develop obesity. We showed that the development of childhood obesity required a much greater increase in calories than previously thought since prior estimates did not properly account for metabolic changes as children grow.
Incidence and severity emerging CVD risk factors may differ between genders
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk factors (i.e. inflammatory and haemostatic markers, endothelial dysfunction, homocysteine, lipid disorders, microalbuminuria/proteinuria, coronary artery calcium score, arterial stiffness, periodontitis, inflammatory bowel syndrome, obstructive sleep apnea, impaired glucose metabolism, metabolic syndrome and non-alcoholic fatty liver disease) are discussed in the context of gender differences.
Synthetic pasta-like objects are major chemistry advances for regenerative medicine
Medicine's recipe for keeping older people active and functioning in their homes and workplaces - and healing younger people injured in catastrophic accidents - may include "noodle gels" and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS).
Cepheid collaborates with Novartis to commercialize BCR-ABL monitoring test
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
› Verified 1 days ago
Chiropractors
Physical Therapists
Optometrists
Podiatrists
Speech-Language Pathologists